Dietary fatty acids and insulin secretion

Scandinavian Journal of Food and Nutrition

Volumn 50, Issue SUPPL. 2, 2006, Pages 79-84

  Mingrone, G ^a,b  

^a CATHOLIC UNIVERSITY   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

Author keywords

Bariatric surgery; Fatty acids; Insulin secretion; Mathematical models

Indexed keywords

ACETYL COENZYME A CARBOXYLASE; ACYL COENZYME A; ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; ARGININE; C PEPTIDE; FATTY ACID; GASTRIC INHIBITORY POLYPEPTIDE; GLUCAGON LIKE PEPTIDE 1; GLUCOSE; GLUCOSE TRANSPORTER 4; INSULIN; LIPID; MESSENGER RNA; MONOUNSATURATED FATTY ACID; PROTEIN KINASE C; SATURATED FATTY ACID; TUMOR NECROSIS FACTOR ALPHA;

BARIATRIC SURGERY; BILIOPANCREATIC BYPASS; CONCENTRATION RESPONSE; CONFERENCE PAPER; FAT INTAKE; GLUCOSE METABOLISM; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN SENSITIVITY; INTRAVENOUS GLUCOSE TOLERANCE TEST; LOW FAT DIET; MALABSORPTION; MATHEMATICAL MODEL; MORBID OBESITY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; ORAL GLUCOSE TOLERANCE TEST; PANCREAS ISLET BETA CELL;

EID: 33845878819     PISSN: 17482976     EISSN: 17482984     Source Type: Journal    
DOI: 10.1080/17482970601076354     Document Type: Conference Paper

References (46)

1. Colberg SR, Simoneau JA, Thaete FL, Kelley DE. Skeletal muscle utilization of free fatty acids in women with visceral obesity. J Clin Invest 1995; 95: 1846-53.
2. Kelley DE, Goodpaster B, Wing RR, Simoneau JA. Skeletal muscle fatty acid metabolism in association with insulin resistance, obesity, and weight loss. Am J Physiol 1999; 277: E1130-41.
3. Kelley DE, Kuller LH, McKolanis TM, Harper P, Mancino J, Kalhan S. Effects of moderate weight loss and orlistat on insulin resistance, regional adiposity, and fatty acids in type 2 diabetes. Diabetes Care 2004; 27: 33-40.
4. Bajaj M, Suraamornkul S, Romanelli A, Cline GW, Mandarino LJ, Shulman GI, et al. Effect of a sustained reduction in plasma free fatty acid concentration on intramuscular long-chain fatty acyl-CoAs and insulin action in type 2 diabetic patients. Diabetes 2005; 54: 3148-53.
5. Crespin SR, Greenough WB, Steinberg D. Stimulation of insulin secretion by infusion of free fatty acids. J Clin Invest 1969; 48: 1934-3.
6. Campillo JE, Valdivia MM, Rodriguez E, Osorio C. Effect of oleic and octanoic acids on glucose-induced insulin release in vitro. Diabete Metab 1979; 5: 183-7.
7. Vara E, Tamarit-Rodriguez J. Glucose stimulation of insulin secretion in islets of fed and starved rats and its dependence on lipid metabolism. Metabolism 1986; 35: 266-71.
8. Sako Y, Grill VE. A 48-hour lipid infusion in the rat time-dependently inhibits glucose-induced insulin secretion and B cell oxidation through a process likely coupled to fatty acid oxidation. Endocrinology 1990; 127: 1580-9.
9. Wolf BA, Pasquale SM, Turk J. Free fatty acid accumulation in secretagogue-stimulated pancreatic islets and effects of arachidonate on depolarization-induced insulin secretion. Biochemistry 1991; 30: 6372-9.
10. Lee Y, Hirose H, Ohneda M, Johnson JH, McGarry JD, Unger RH. B-cell lipotoxicity in the pathogenesis of non-insulin-dependent diabetes mellitus of obese rats: impairment in adipocyte-β-cell relationships. Proc Natl Acad Sci USA 1994; 91: 10878-82.
11. + channels in pancreatic β-cells. Diabetes 1997; 46: 1087-93.
12. Zhou Y-T, Shimabukuro M, Lee Y, Koyama K, Higa M, Ferguson T, et al. Enhanced de novo lipogenesis in the leptin-unresponsive pancreatic islets of prediabetic Zucker diabetic fatty rats: role in the pathogenesis of lipotoxic diabetes. Diabetes 1998; 47: 1904-8.
13. Shimabukuro M, Higa M, Zhou Y-T, Wang M-Y, Newgard CB, Unger RH. Lipoapoptosis in the β-cells of obese prediabetic fa/fa rats: role of serine palmitoyl-transferase overexpression. J Biol Chem 1998; 49: 32487-90.
14. Prentki M, Vischer S, Glennon MC, Regazzi R, Deeney JT, Corkey BE. Malonyl-CoA and long chain acyl-CoA esters as metabolic coupling factors in nutrient-induced insulin secretion. J Biol Chem 1992; 267: 5802-10.
15. Unger RH. Lipotoxicity in the pathogenesis of obesity-dependent NIDDM. Genetic and clinical implications. Diabetes 1995; 44: 863-70.
16. Stein DT, Esser V, Stevenson B, Lane KE, Whiteside JH, Daniels MB, et al. Essentiality of circulating fatty acids for glucose-stimulated insulin secretion in the fasted rat. J Clin Invest 1996; 97: 2728-35.
17. Stein DT, Stevenson B, Chester MW, Basit M, Daniels MB, Turley SD, et al. The insulinotropic potency of fatty acids is influenced profoundly by their chain length and degree of saturation. J Clin Invest 1997; 100: 398-403.
18. Dobbins R, McGarry JD, Stein DT. Normal glucose stimulated insulin secretion is dependent on free fatty acids in the 24-°to 48-hour fasted human. Diabetes 1997; 46: 50-4.
19. Hovorka R, Jones RH. How to measure insulin secretion. Diabetes Metab Rev 1994; 10: 91-117.
20. Eaton RP, Allen RC, Schade DS, Erickson KM, Standefer J. Prehepatic insulin production in man: kinetic analysis using peripheral connecting peptide behavior. J Clin Endocrinol Metab 1980; 51: 520-8.
21. Polonsky KS, Rubenstein AH. Current approaches to measurement of insulin secretion. Diabetes Metab Rev 1986; 2: 315-29.
22. Van Cauter E, Mestrez F, Sturis J, Polonsky KS. Estimation of insulin secretion rates from C-peptide levels. Comparison of individual and standard kinetic parameters for C-peptide clearance. Diabetes 1992; 41: 368-77.
23. Bergman RN, Phillips LS, Cobelli C. Physiologic evaluation of factors controlling glucose tolerance in man: measurement of insulin sensitivity and B-cell glucose sensitivity from the response to intravenous glucose. J Clin Invest 1981; 68: 1456-67.
24. Yaney GC, Corkey BE. Fatty acid metabolism and insulin secretion in pancreatic beta cells. Diabetologia 2003; 46: 1297-312.
25. Prentki M, Tornheim K, Corkey BE. Signal transduction mechanisms in nutrient-induced insulin secretion. Diabetologia 1997; 40: S32-41.
26. + channel-independent glucose action in rat pancreatic beta-cell. Am J Physiol 1994; 266: C622-7.
27. + channels in mouse B cells. J Clin Invest 1993; 91: 871-80.
28. 2+ in rat pancreatic islets. Proc Natl Acad Sci USA 1995; 92: 10728-32.
29. +. Diabetes 1998; 47: 352-7.
30. Mari A, Schmitz O, Gastaldelli A, Oestergaard T, Nyholm B, Ferrannini E. Meal and oral glucose tests for assessment of beta β-cell function: modelling analysis in normal subjects. Am J Physiol Endocrinol Metab 2002; 283: E1159-66.
31. Sullivan DR, Yue DK, Capogreco C, McLennan S, Nicks J, Cooney G, et al. The effects of dietary n-3 fatty acid in animal models of type 1 and type 2 diabetes. Diabetes Res Clin Pract 1990; 9: 225-30.
32. Thomsen C, Rasmussen O, Lousen T, Holst JJ, Fenselau S, Schrezenmeir J, et al. Differential effects of saturated and monounsaturated fatty acids on postprandial lipemia and incretin responses in healthy subjects. Am J Clin Nutr 1999; 69: 1135-43.
33. Vessby B, Unsitupa M, Hermansen K, Riccardi G, Rivellese AA, Tapsell LC, et al. Substituting dietary saturated for monounsaturated fat impairs insulin sensitivity in healthy men and women: The KANWU Study. Diabetologia 2001; 44: 312-9.
34. Tuomilehto J, Lindstrom J, Eriksson JG, Valle TT, Hamalainen H, Ilanne-Parikka P, et al. Finnish Diabetes Prevention Study Group. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001; 344: 1343-50.
35. Schulze MB, Hoffmann K, Manson JE, Willett WC, Meigs JB, Weikert C, et al. Dietary pattern, inflammation, and incidence of type 2 diabetes in women. Am J Clin Nutr 2005; 82: 675-84.
36. Virtanen SM, Feskens EJ, Rasanen L, Fidanza F, Tuomilehto J, Giampaoli S, et al. Comparison of diets of diabetic and non-diabetic elderly men in Finland, The Netherlands and Italy. Eur J Clin Nutr 2000; 54: 181-6.
37. Boden G. Free fatty acids - the link between obesity and insulin resistance. Endocr Pract 2001; 7: 44-51.
38. Perseghin G, Ghosh S, Gerow K, Shulman GI. Metabolic defects in lean nondiabetic offspring of NIDDM parents: a cross-sectional study. Diabetes 1997; 46: 1001-9.
39. Greco AV, Mingrone G, Giancaterini A, Manco M, Morroni M, Cinti S, et al. Insulin resistance in morbid obesity: reversal with intramyocellular fat depletion. Diabetes 2002; 51: 144-51.
40. Mingrone G, DeGaetano A, Greco AV, Capristo E, Benedetti G, Castagneto M, et al. Reversibility of insulin resistance in obese diabetic patients: role of plasma lipids. Diabetologia 1997; 40: 599-605.
41. Mingrone G, Rosa G, Di Rocco P, Manco M, Capristo E, Castagneto M, et al. Skeletal muscle triglycerides lowering is associated with net improvement of insulin sensitivity, TNF-alpha reduction and GLUT4 expression enhancement. Int J Obes Relat Metab Disord 2002; 26: 1165-72.
42. Mingrone G, Manco M, Granato L, Calvani M, Scarfone A, Mora EV, et al. Leptin pulsatility in formerly obese women. FASEB J 2005; 19: 1380-2.
43. Rosa G, Di Rocco P, Manco M, Greco AV, Castagneto M, Vidal H, et al. Reduced PDK4 expression associates with increased insulin sensitivity in postobese patients. Obes Res 2003; 11: 176-82.
44. Mingrone G, Henriksen FL, Greco AV, Krogh LN, Capristo E, Gastaldelli A, et al. Triglyceride-induced diabetes associated with familial lipoprotein lipase deficiency. Diabetes 1999; 48: 1258-63.
45. Guidone C, Manco M, Valera-Mora E, Iaconelli A, Gniuli D, Mari A, et al. Mechanisms of recovery from type 2 diabetes mellitus after malabsorptive bariatric surgery. Diabetes 2006; 55: 2025-31.
46. Mari A., Manco M, Guidone C, Nanni G., Castagneto M, Mingrone G, et al. Restoration of normal glucose tolerance in severely obese patients after bilio-pancreatic diversion: role of insulin sensitivity and beta cell function. Diabetologia 2006; 49: 2136-43.